FDA: Mifepristone review won’t be done until March

A safety review that takes until March, plus a promise to change nothing before it lands. That's not a review, it's a calendar.

The Food and Drug Administration (FDA) won’t publish its safety review of the abortion drug mifepristone until March, it disclosed in a Wednesday court filing, adding that it won’t impose any new restrictions on the pill before that point. The revelations are likely to further anger anti-abortion activists, who have been losing patience with the…

Read it at The Hill ↗

← Front page